Herduo Lapatinib I.P.250mg

Herduo is used together with another medication which is used to treat  certain type of breast cancer (HER2 positive)  and it is also used to treat HER2 positive breast cancer in women after menopause. It works by slowing or stopping the growth of cancer cells. To buy Herduo or to know its price contact 3S corporation.

Manufacturer : Natco Pharma Limited

Strengths available :  I.P. 250mg

Form :  Tablets

Storage : Store at 25°C; excursions permitted to 15°C to 30°C

Dosage : HER2-Positive Metastatic Breast Cancer-The recommended dose is 1,250 mg given orally once daily on Days 1-21 continuously in combination with capecitabine 2,000 mg/m²/day (administered orally in 2 doses approximately 12 hours apart) on Days 1-14 in a repeating 21-day cycle. This medicine should be taken at least one hour before or one hour after a meal. The dose should be once daily (5 tablets administered all at once); dividing the daily dose is not recommended. Capecitabine should be taken with food or within 30 minutes after food. If a day’s dose is missed, the patient should not double the dose the next day. Treatment should be continued until disease progression or unacceptable toxicity occurs.

Hormone Receptor-Positive, HER2-Positive Metastatic Breast Cancer-The recommended dose of is 1,500 mg given orally once daily continuously in combination with letrozole.

Common side effects are nausea, stomach upset, mouth sores, mild rash, dry skin, trouble in sleeping.

Pack of 150 tablets